Progesterone 200 mg Soft Capsule (JSC Farmak, Ukraine)

DRUG2 trials

Sponsors

Joint Stock Company Farmak

Conditions

Pharmacokinetics

Phase 1

Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects

CompletedNCT05125640

Joint Stock Company FarmakPharmacokinetics

Start: 2019-12-13End: 2020-01-07Updated: 2021-11-18

Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route

CompletedNCT05125627

Joint Stock Company FarmakPharmacokinetics

Start: 2019-08-28End: 2019-10-21Updated: 2021-11-18